1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      An Isoform-Specific Myristylation Switch Targets Type II PKA Holoenzymes to Membranes.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cyclic AMP-dependent protein kinase (PKA) is regulated in part by N-terminal myristylation of its catalytic (C) subunit. Structural information about the role of myristylation in membrane targeting of PKA has been limited. In mammalian cells there are four functionally non-redundant PKA regulatory subunits (RIα, RIβ, RIIα, and RIIβ). PKA is assembled as an inactive R2C2 holoenzyme in cells. To explore the role of N-myristylation in membrane targeting of PKA holoenzymes, we solved crystal structures of RIα:myrC and RIIβ2:myrC2, and showed that the N-terminal myristylation site in the myrC serves as a flexible "switch" that can potentially be mobilized for membrane anchoring of RII, but not RI, holoenzymes. Furthermore, we synthesized nanodiscs and showed by electron microscopy that membrane targeting through the myristic acid is specific for the RII holoenzyme. This membrane-anchoring myristylation switch is independent of A Kinase Anchoring Proteins (AKAPs) that target PKA to membranes by other mechanisms.

          Related collections

          Author and article information

          Journal
          Structure
          Structure (London, England : 1993)
          1878-4186
          0969-2126
          Sep 1 2015
          : 23
          : 9
          Affiliations
          [1 ] Department of Pharmacology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA.
          [2 ] Department of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA.
          [3 ] Department of Pharmacology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA; Department of Chemistry and Biochemistry, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA.
          [4 ] Department of Pharmacology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA; Department of Chemistry and Biochemistry, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0654, USA. Electronic address: staylor@ucsd.edu.
          Article
          S0969-2126(15)00288-9 NIHMS713754
          10.1016/j.str.2015.07.007
          4558360
          26278174
          f08a2a2d-2dda-4d18-8394-f273ed39d603
          Copyright © 2015 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article